US Bank Run Has Slowed To A Walk, But Instability Remains

When Ravi Chopra reveals his stock pick at the prestigious Sohn Hearts & Minds conference at the Opera House in Sydney next month, it could well be a short bet on a US bank.
Ravi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn Licht

David Rogers

US Bank Run Has Slowed To A Walk, But Instability Remains

October 23, 2023
When Ravi Chopra reveals his stock pick at the prestigious Sohn Hearts & Minds conference at the Opera House in Sydney next month, it could well be a short bet on a US bank.
Read Transcript

When Ravi Chopra reveals his stock pick at the prestigious Sohn Hearts & Minds conference at the Opera House in Sydney next month, it could well be a short bet on a US bank.

When Ravi Chopra reveals his stock pick at the prestigious Sohn Hearts & Minds conference at the Opera House in Sydney on November 17, it could well be a short bet on a US bank.

Chopra is the chief investment office and founder of Azora Capital, a long-short hedge fund investing only in US financial services companies. As the US 10-year Treasury yield soars to 5 per cent, he says the interest rate and liquidity risk that caused the regional banking crisis in March is still out there.

He started out as an investment banking analyst at Goldman Sachs during the tech wreck, before working as a financial services analyst at Sigma Capital, a subsidiary of Steve Cohen’s SAC Capital Advisers.

In the global financial crisis he was a partner and sector head of financial services at Sigma offshoot Samlyn Capital.

His most profitable times as a fund manager have been during crises – the GFC, the coronavirus crash of March 2020, and the US regional banking crisis of March this year.

Azora had its best year ever in 2020 when US interest rates were cut to the lowest level in history.

March 2023 was its best month ever – Azora was short each of the four banks that failed.

A full year before the US regional bank failures of 2023, Chopra warned of the “tragic positioning” of some banks in terms of their investment portfolios, concluding there was “no way out”. Swift action by the Fed saved the day back then, but the warnings are still flashing red.

Chopra explains that the GFC stemmed from poorly underwritten credit and credit losses that dwarfed bank capital. So for the past 15 years, bank management teams, rating agencies and regulators have been stress-testing for credit and capital.

But they underestimated the interest rate and liquidity risks from pandemic-era monetary policy.

Unlike the GFC, where credit losses dominated, losses stemming from interest rate risk mismanagement in the current cycle will end up dwarfing losses from credit risk, Chopra says.

It started when the Fed slashed its funds rate from 2.5 per cent to zero in March 2022 and began a $US5 trillion quantitative easing program, lowering the 10-year Treasury bond yield to a record low of 32 basis points, and effectively pushing $US5 trillion on to bank balance sheets.

Typically, the US banking industry sees steady deposit growth of about 6 per cent per annum.

But in 2021, deposits leapt by an unheard of 35 per cent, most of it non-interest bearing deposits.

Some banks hoovered up a disproportionate share of those deposits.

They were typically in growth industries like technology, biotechnology and cryptocurrency.

Thanks to the massive growth in deposits, they experienced huge share price growth.

Some bank’s “carry trades” in 1 to 1.5 per cent yielding securities with 10-year maturities, funded by zero-cost non-interest-bearing deposits, were multiples of the size of the existing banks in 2019.

Then the Fed raised interest rates at the fastest pace since the 1970s and started quantitative tightening that wiped $US700bn off the value of the banking industry’s fixed-rate assets.

That was about 60 per cent of the capital base of the entire banking industry, which was similar to the peak of the GFC in terms of credit losses as a percentage of capital in the US banking industry.

Higher interest rates also make it hard for some banks to keep funding their deposits.

Azora’s analysis, marking-to-market bank balance sheets for the new interest rate environment and the unrealised losses of bond portfolios, found many banks were undercapitalised. Some were mathematically insolvent. It also looked at liquidity risks, using the percentage of each bank’s deposits that were uninsured, to come up with its list of short selling targets.

But Chopra still worries about the “recency bias” of financial institutions and regulators amid a structural shift to higher inflation and interest rates after a long period of falling inflation and rates.

“We’ve been conditioned since the GFC to think that anytime the economy sneezed, anytime there was trouble in the world, the Fed was going to cut rates and buy bonds,” he says. “It was inconceivable to think that just two years after a global pandemic that we’ve never seen in our lives, the Fed could be raising interest rates 500 basis points.”

He also notes that while the Fed’s Bank Term Funding facility allowed banks to post assets as collateral at face value in exchange for funding, legislative difficulties prevented regulators from guaranteeing deposits in excess of the $US250,000 limit as they did in the GFC.

“That was the ‘ah ha’ moment for depositors,” Chopra says.

“For the first time perhaps, depositors realised they were actually unsecured lenders to these banks, and they weren’t even getting paid for it.”

The day after the Fed’s BTF facility was announced, some banks’ share prices fell 30-50 per cent.

Bank “runs” have stopped, but bank “walks” continue, as the regional banking crisis showed depositors they were taking on an intended credit risk for no return,

They’re shifting to mutual funds paying 5.5 per cent risk free.

“To be clear, if you have zero-cost funding that’s leaving, you now have to replace that with market-rate funding. Market-rate funding could now cost you 5.5 to 6 per cent,” Chopra says.

Free money leaving and 6 per cent coming in is a big problem for the banks. He also worries that US interest rates will continue to rise, worsening unrealised losses on bond portfolios, pushing banks to use “break glass in emergency” funding to pay their depositors.

“They can cut their dividends, or raise equity capital, but no financial institution wants to go down that route – a dividend cut is a really negative signal, and a capital raise is what precipitated the failure of Silicon Valley Bank – no one wants to be the guinea pig to try that right now.”

He says to the extent that banks are looking to scale back their lending to improve their capital ratios, it will tighten their underwriting standards and weaken their loan growth. With that comes rising loan losses, because as liquidity leaves the system, it’s harder to get a loan.

“Credit bubbles start popping, and one area is commercial real estate,” Chopra says.

“Sixty per cent of all commercial real estate loans are made by the banking system, two-thirds of those are made by the smallest banks, where some of the issues are the most acute. That has led to a near complete dry-up of liquidity in certain areas of the commercial real estate market, particularly the office market, which portends greater losses to come from credit.”

Sohn Hearts & Minds delivers stock picks from investment experts around the globe, with all profits raised going to medical research. The conference is on track to raise $60m by November.

The Australian is a media partner.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

When Ravi Chopra reveals his stock pick at the prestigious Sohn Hearts & Minds conference at the Opera House in Sydney next month, it could well be a short bet on a US bank.

When Ravi Chopra reveals his stock pick at the prestigious Sohn Hearts & Minds conference at the Opera House in Sydney on November 17, it could well be a short bet on a US bank.

Chopra is the chief investment office and founder of Azora Capital, a long-short hedge fund investing only in US financial services companies. As the US 10-year Treasury yield soars to 5 per cent, he says the interest rate and liquidity risk that caused the regional banking crisis in March is still out there.

He started out as an investment banking analyst at Goldman Sachs during the tech wreck, before working as a financial services analyst at Sigma Capital, a subsidiary of Steve Cohen’s SAC Capital Advisers.

In the global financial crisis he was a partner and sector head of financial services at Sigma offshoot Samlyn Capital.

His most profitable times as a fund manager have been during crises – the GFC, the coronavirus crash of March 2020, and the US regional banking crisis of March this year.

Azora had its best year ever in 2020 when US interest rates were cut to the lowest level in history.

March 2023 was its best month ever – Azora was short each of the four banks that failed.

A full year before the US regional bank failures of 2023, Chopra warned of the “tragic positioning” of some banks in terms of their investment portfolios, concluding there was “no way out”. Swift action by the Fed saved the day back then, but the warnings are still flashing red.

Chopra explains that the GFC stemmed from poorly underwritten credit and credit losses that dwarfed bank capital. So for the past 15 years, bank management teams, rating agencies and regulators have been stress-testing for credit and capital.

But they underestimated the interest rate and liquidity risks from pandemic-era monetary policy.

Unlike the GFC, where credit losses dominated, losses stemming from interest rate risk mismanagement in the current cycle will end up dwarfing losses from credit risk, Chopra says.

It started when the Fed slashed its funds rate from 2.5 per cent to zero in March 2022 and began a $US5 trillion quantitative easing program, lowering the 10-year Treasury bond yield to a record low of 32 basis points, and effectively pushing $US5 trillion on to bank balance sheets.

Typically, the US banking industry sees steady deposit growth of about 6 per cent per annum.

But in 2021, deposits leapt by an unheard of 35 per cent, most of it non-interest bearing deposits.

Some banks hoovered up a disproportionate share of those deposits.

They were typically in growth industries like technology, biotechnology and cryptocurrency.

Thanks to the massive growth in deposits, they experienced huge share price growth.

Some bank’s “carry trades” in 1 to 1.5 per cent yielding securities with 10-year maturities, funded by zero-cost non-interest-bearing deposits, were multiples of the size of the existing banks in 2019.

Then the Fed raised interest rates at the fastest pace since the 1970s and started quantitative tightening that wiped $US700bn off the value of the banking industry’s fixed-rate assets.

That was about 60 per cent of the capital base of the entire banking industry, which was similar to the peak of the GFC in terms of credit losses as a percentage of capital in the US banking industry.

Higher interest rates also make it hard for some banks to keep funding their deposits.

Azora’s analysis, marking-to-market bank balance sheets for the new interest rate environment and the unrealised losses of bond portfolios, found many banks were undercapitalised. Some were mathematically insolvent. It also looked at liquidity risks, using the percentage of each bank’s deposits that were uninsured, to come up with its list of short selling targets.

But Chopra still worries about the “recency bias” of financial institutions and regulators amid a structural shift to higher inflation and interest rates after a long period of falling inflation and rates.

“We’ve been conditioned since the GFC to think that anytime the economy sneezed, anytime there was trouble in the world, the Fed was going to cut rates and buy bonds,” he says. “It was inconceivable to think that just two years after a global pandemic that we’ve never seen in our lives, the Fed could be raising interest rates 500 basis points.”

He also notes that while the Fed’s Bank Term Funding facility allowed banks to post assets as collateral at face value in exchange for funding, legislative difficulties prevented regulators from guaranteeing deposits in excess of the $US250,000 limit as they did in the GFC.

“That was the ‘ah ha’ moment for depositors,” Chopra says.

“For the first time perhaps, depositors realised they were actually unsecured lenders to these banks, and they weren’t even getting paid for it.”

The day after the Fed’s BTF facility was announced, some banks’ share prices fell 30-50 per cent.

Bank “runs” have stopped, but bank “walks” continue, as the regional banking crisis showed depositors they were taking on an intended credit risk for no return,

They’re shifting to mutual funds paying 5.5 per cent risk free.

“To be clear, if you have zero-cost funding that’s leaving, you now have to replace that with market-rate funding. Market-rate funding could now cost you 5.5 to 6 per cent,” Chopra says.

Free money leaving and 6 per cent coming in is a big problem for the banks. He also worries that US interest rates will continue to rise, worsening unrealised losses on bond portfolios, pushing banks to use “break glass in emergency” funding to pay their depositors.

“They can cut their dividends, or raise equity capital, but no financial institution wants to go down that route – a dividend cut is a really negative signal, and a capital raise is what precipitated the failure of Silicon Valley Bank – no one wants to be the guinea pig to try that right now.”

He says to the extent that banks are looking to scale back their lending to improve their capital ratios, it will tighten their underwriting standards and weaken their loan growth. With that comes rising loan losses, because as liquidity leaves the system, it’s harder to get a loan.

“Credit bubbles start popping, and one area is commercial real estate,” Chopra says.

“Sixty per cent of all commercial real estate loans are made by the banking system, two-thirds of those are made by the smallest banks, where some of the issues are the most acute. That has led to a near complete dry-up of liquidity in certain areas of the commercial real estate market, particularly the office market, which portends greater losses to come from credit.”

Sohn Hearts & Minds delivers stock picks from investment experts around the globe, with all profits raised going to medical research. The conference is on track to raise $60m by November.

The Australian is a media partner.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Oct 23, 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
March 14, 2025

$1.4 million boost for SA medical research

South Australian medical research will receive a $1.4 million cash injection, as a direct result of a major investment and philanthropy conference held in Adelaide.

Read More
Anthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. AP
May 19, 2025

Why ‘The Mooch’ thinks Trump is more dangerous this time around

Anthony Scaramucci says Trump has fewer constraints on his worst instincts in his second administration. But he still gets bored easily.

Read More
Image caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn Licht
May 19, 2025

My biggest mistake: Anthony Scaramucci on what makes Donald Trump tick

On Elon Musk, money and the White House, fast-talking Wall Street hedge fund manager and former Trump communications director Anthony Scaramucci tells it as he sees it.

Read More
A bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFP
May 19, 2025

Bitcoin ‘on track’ for $US200,000: Anthony Scaramucci

Bitcoin could hit as much as $US200,000 ($311,000) by the end of this year, fuelled by surging inflows into exchange-traded funds and Donald Trump’s erratic policymaking.

Read More
Anthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn Licht
May 19, 2025

‘The Mooch’ says Trump will have to cut China tariffs below 10pc

Scaramucci, who is best known as The Mooch, is the first big-name global investor to be confirmed for the Sohn Hearts & Minds conference in Sydney in November.

Read More
December 19, 2024

Rikki Bannan – Don’t get caught up in momentum

Conference Fund Manager Rikki Bannan, Executive Director at IFM Investors, joins Equity Mates to discuss her standout 2023 stock pick, Telix, and explore what opportunities lie ahead.

Read More
Nick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben Searcy
November 20, 2024

Trump unifies top investors in decade-long bullish outlook for US

Nick Moakes, CIO of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.

Read More
Wall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben Searcy
November 17, 2024

Is anyone brave or stupid enough to bet against America?

Stock pickers have been punished for betting against the US. The choice between consensus and contrarianism on American exceptionalism is now harder than ever.

Read More
Ellerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy Photography
November 15, 2024

Eleven stock tips from Sohn to get you through 2025

“There’s no finer place for the finance festival than in the festival city,” said Matthew Grounds. He, along with fellow Barrenjoey co-executive chairman Guy Fowler and investor Gary Weiss, is one of Sohn’s driving forces.

Read More
November 15, 2024

Howard Marks and Sohn’s big stars reveal seven rules for investing

Among the stock picks and stunts at the Sohh Hearts & Minds event, Howard Marks and Nick Moakes provided investors with long-term rules for playing markets.

Read More
November 15, 2024

Sohn ASX stock pick: Ellerston Capital’s Chris Kourtis backs Perpetual

Chris Kourtis has put his biggest bet on embattled Perpetual – picking one of the most hated stocks on the ASX – that he believes will soon be the ‘cheapest listed asset manager of scale in the universe’.

Read More
Markets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFPMarkets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFPMarkets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFPMarkets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFP
November 15, 2024

Sohn investors position for bullish but bumpy Trump ride

Australia and the rest of the world must adjust to a new Trump presidency that will deliver an expected bull market but also disruption, with the leader in waiting prepared to “create pain” to get his way.

Read More
November 15, 2024

Sohn stock picker experts name best shares to invest in for year ahead

‍Don’t overlook down and out silver miners, legacy skincare brands ready for a revival and a big financial company suffering from a severe case of shareholder wealth destruction.

Read More
November 15, 2024

Sohn: NYSE-listed Estee Lauder’s Northcape Capital pick

Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

Read More
Mike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/Bloomberg
November 9, 2024

Galaxy Digital CEO Mike Novogratz believes bitcoin will hit $US100k

Bitcoin’s bounce to record highs in recent days is only the beginning of a fresh surge higher for cryptocurrency, says US billionaire Mike Novogratz.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lancaster sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.